FNY Investment Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32K | Buy |
2,300
+1,500
| +188% | +$20.9K | 0.01% | 488 |
|
2025
Q1 | $19K | Buy |
+800
| New | +$19K | 0.01% | 412 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 858 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 835 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 801 |
|
2023
Q1 | – | Sell |
-250
| Closed | -$3K | – | 872 |
|
2022
Q4 | $3K | Sell |
250
-263,322
| -100% | -$3.16M | ﹤0.01% | 378 |
|
2022
Q3 | $1.66M | Buy |
263,572
+253,692
| +2,568% | +$1.6M | 1.15% | 22 |
|
2022
Q2 | $1.44M | Buy |
+9,880
| New | +$1.44M | 1.06% | 25 |
|
2019
Q3 | – | Sell |
-22,600
| Closed | -$989K | – | 1314 |
|
2019
Q2 | $989K | Buy |
+22,600
| New | +$989K | 0.29% | 44 |
|